.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Colorcon
Argus Health
McKesson
Boehringer Ingelheim
US Department of Justice
Healthtrust
Teva
Harvard Business School
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

Ferric pyrophosphate citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for ferric pyrophosphate citrate and what is the scope of ferric pyrophosphate citrate freedom to operate?

Ferric pyrophosphate citrate
is the generic ingredient in one branded drug marketed by Rockwell Medical Inc and is included in two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric pyrophosphate citrate has thirty-six patent family members in twenty-one countries.

There are fourteen drug master file entries for ferric pyrophosphate citrate. Two suppliers are listed for this compound.

Summary for ferric pyrophosphate citrate

Pharmacology for ferric pyrophosphate citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Rockwell Medical IncTRIFERICferric pyrophosphate citrateSOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Rockwell Medical IncTRIFERICferric pyrophosphate citrateSOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Rockwell Medical IncTRIFERICferric pyrophosphate citrateSOLUTION;IV (INFUSION)206317-002Sep 4, 2015RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Rockwell Medical IncTRIFERICferric pyrophosphate citrateSOLUTION;IV (INFUSION)206317-001Jan 23, 2015RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Rockwell Medical IncTRIFERIC ferric pyrophosphate citrateFOR SOLUTION;INTRAVENOUS208551-001Apr 25, 2016RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ferric pyrophosphate citrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Rockwell Medical IncTRIFERICferric pyrophosphate citrateSOLUTION;IV (INFUSION)206317-001Jan 23, 2015► Subscribe► Subscribe
Rockwell Medical IncTRIFERICferric pyrophosphate citrateSOLUTION;IV (INFUSION)206317-001Jan 23, 2015► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ferric pyrophosphate citrate

Country Document Number Estimated Expiration
Japan2002531051► Subscribe
European Patent Office2016940► Subscribe
Eurasian Patent Organization002479► Subscribe
Slovenia2016940► Subscribe
Hong Kong1023350► Subscribe
Germany69734781► Subscribe
Cyprus1113903► Subscribe
Poland191377► Subscribe
Poland334437► Subscribe
Portugal2016940► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Fuji
Citi
Federal Trade Commission
Baxter
Farmers Insurance
QuintilesIMS
Moodys
McKinsey
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot